Updates are available Correction dated 2024-03-21

Article History

Received: 19 July 2023

Accepted: 30 August 2023

First Online: 12 September 2023

Change Date: 21 March 2024

Change Type: Correction

Change Details: A Correction to this paper has been published:

Change Details: https://doi.org/10.1186/s13756-024-01387-4

Declarations

:

: Not applicable.

: Not applicable.

: PLL has received support for attending meetings and/or travel from Shionogi. PL has received payment or honoraria for lectures, presentations, speakers’ bureaus, or educational events from AstraZeneca, GSK, Janssen, MSD, Moderna, Pfizer, Sanofi Pasteur, and support for attending meetings and/or travel from AstraZeneca, Pfizer, and Sanofi Pasteur. AS has received consulting fees from Besins Healthcare and Karo Pharma, support for attending meetings and/or travel from Pfizer and MSD and participates free of charge on advisory boards of Biofilm Control and CTX Laboratory. RL has received consulting fees from MSD, payment or honoraria for lectures, presentations, speakers’ bureaus, or educational events from BioM?rieux, MSD, Pfizer and Shionogi, and support for attending meetings and/or travel from BioM?rieux, Roche Diagnostics, MSD, Pfizer and Shionogi. All other authors declare that they have no conflict of interest.